495-84-1
495-84-1
Chemical Structure
Salinazid
- CAS No.: 495-84-1
- Formula:C13H11N3O2
- Molecular Weight:241.25
IUPAC Name: (E)-N'-(2-hydroxybenzylidene)isonicotinohydrazide
InChIKey: VBIZUNYMJSPHBH-OQLLNIDSSA-N
SMILES: O=C(C1=CC=NC=C1)N/N=C/C2=CC=CC=C2O
Biological Activity: Salinazid is an antituberculous compound[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Salinazid | 99.62% | Salinazid is an antituberculous compound. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
AS8351 | 99.88% | AS8351 (NSC51355) is a KDM5B inhibitor, which can induce and sustain active chromatin marks to facilitate the induction of cardiomyocyte-like cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RSVA405 | 99.72% | RSVA405 is a potent, orally active activator of AMPK, with an EC50 of 1 μM. RSVA405 facilitates CaMKKβ-dependent activation of AMPK, inhibits mTOR, and promotes autophagy to increase Aβ degradation. RSVA405 has anti-inflammatory effects through the inhibition of STAT3 function. RSVA405 can also be used for the research of obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SCS (Standard) | ≥98% | SCS (Standard) is the analytical standard of SCS (HY-103528). This product is intended for research and analytical applications. SCS (Salicylidene salicylhydrazide) is a potent, allosteric and selective inhibitor of β1-containing GABAA receptors with an IC50 of 32 nM against α2β1γ1θ by VIPR measurement. SCS is also a chelator of metal ions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Aconiazide | Aconiazide (Isonicophen) is a orally active hydrazone derivative of isoniazid, and can be used for study of tuberculosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Androgen receptor ligand 4 | 96.68% | Androgen receptor ligand 4 (Compound MDG486) is an androgen receptor ligand with an IC50 of >100 µM. Androgen receptor ligand 4 can be used in the research of adolescent development. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
KM91104 | 98.06% | KM91104 is a cell-permeable V-ATPase a3-b2 inhibitor (IC50 = 2.3 µM). KM91104 reduces the metabolic activity, cell proliferation capacity and V-ATPase subunit protein expression levels of primary human hepatic stellate cells, increases intracellular ATP levels and decreases cytoplasmic pH. KM91104 reduces TLR4 expression on the surface of oligodendrocyte precursor cells, blocks the ENV-TLR4 interaction, and reverses oligodendrocyte myelination defects induced by ENV protein. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HDZI 2,4OH | HDZI 2,4OH exerts significant anti anxiety activity through GABA receptors. HDZI 2,4OH can penetrate the blood-brain barrier. HDZI 2,4OH exhibits low toxicity in zebrafish. HDZI 2,4OH can be used for research on neurological disorders such as anxiety disorders. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N'-(Pyridin-4-ylmethylene)isonicotinohydrazide | ||||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ftivazide (Standard) | ≥98% | Ftivazide (Standard) is the analytical standard of Ftivazide. This product is intended for research and analytical applications. Ftivazide has anti-tuberculosis activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
TJU103 | TJU103 is a CD4 inhibitor. TJU103 inhibits autoreactive CD4+ T cells by disrupting the function of the CD4 during activation. TJU103 decreases mononuclear cell infiltration in brain and spinal cord tissue of experimental allergic encephalomyelitis (EAE) mice model. TJU103 downregulates Th1 and Th2 cytokine levels in response to proteolipid protein epitope 139-151 (PLPe) and exhibits inhibitory effects both after the appearance of EAE symptoms and upon rechallenge with Ag. TJU103 can be used for autoimmune diseases like EAE and sclerosis (MS) research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
